Evidence map›Paper›PMID 29930380›Full record

ArticleOncogene2018

PHLPP2 stabilization by p27 mediates its inhibition of bladder cancer invasion by promoting autophagic degradation of MMP2 protein.

Minggang Peng, Jingjing Wang, Dongyun Zhang, Honglei Jin, Jingxia Li, Xue-Ru Wu, Chuanshu Huang

Open access · hybridAbstract read
In one paragraph

Article in Oncogene, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. PHLPP2: A Prognostic Biomarker in Adenocarcinoma of the Rectum.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. p27Cells · 2021
    Review
  9. Article
  10. Oncogenic role ofAutophagy · 2021
    Article
  11. Article
  12. Contrast effects of autophagy in the treatment of bladder cancer.Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Cancer management and research · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Minggang PengNelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY, 10987, USA.
Jingjing WangNelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY, 10987, USA.
Dongyun ZhangNelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY, 10987, USA.
Honglei JinSchool of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Jingxia LiNelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY, 10987, USA.
Xue-Ru WuDepartments of Urology and Pathology, New York University School of Medicine, New York, NY, 10016, USA.
Chuanshu HuangNelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY, 10987, USA. Chuanshu.huang@nyumc.org.
New York University · USWenzhou Medical University · CN

Funding

RESEARCH IN ENVIRONMENTAL HEALTH SCIENCES (CENTER GRANT)P30ES000260 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ZELIKOFF, JUDITH TERRY · 1985 to 2020
$26.1M
Reagent/Service CoreP01CA165980 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WU, XUE-RU · 2013 to 2023
$13.5M
SESN2 and therapeutic effect of Isohapontigenin (ISO)R01CA217923 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COSTA, MAX, SUN, HONG · 2018 to 2022
$2.1M
Mechanisms underlying therapeutic effect of a new compound Isorhapontigenin (ISO)R01CA177665 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HUANG, CHUANSHU · 2013 to 2018
$1.7M
NCI NIH HHS P01 CA165980NCI NIH HHS R01 CA177665NCI NIH HHS R01 CA217923NIEHS NIH HHS P30 ES000260
6 · The paper itself

Abstract

Pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2) is a tumor suppressor that catalyzes the de-phosphorylation of the AGC kinases, while p27 acts as a tumor suppressor that regulates cell cycle, apoptosis, and cell motility. Our previous studies have identified that PHLPP2 participates in inhibition of transformation of human bronchial epithelial cells following lung carcinogen B[a]P/B[a]PDE exposure. However, nothing was known about the association of p27 with regulation of PHLPP2 expression and the role of PHLPP2 in bladder cancer (BC) invasion. In our current studies, we demonstrated that PHLPP2 inhibited BC invasion through promoting MMP2 degradation via p62-mediated autophagy; and p27 expression was able to stabilize PHLPP2 protein by inhibiting protein degradation of Hsp90, which could directly bind to PHLPP2 and protect it from degradation. More in-depth studies discovered that stabilization of Hsp90 by p27 was mediated by calpain1 proteolysis system, whereas p27 inhibited calpain1 gene transcription by attenuating Jak1/Stat1 cascade in human invasive BC cells. Collectively, we for the first time revealed PHLPP2 downregulation in BCs and its participating in promotion of BC invasion, as well as novel role of p27 and mechanisms underlying its regulation of PHLPP2 protein degradation through Hsp90-dependent manner. Our findings improve our understanding of p27 and PHLPP2 roles and their crosstalk in regulation of BC invasion, which further contributes to improve the current strategy for invasive bladder cancer therapy.

Indexed as

AutophagyProteolysisUrinary Bladder NeoplasmsAnimalsCyclin-Dependent Kinase Inhibitor p27Gene Expression Regulation, NeoplasticHumansMatrix Metalloproteinase 2MiceMice, KnockoutNeoplasm InvasivenessNeoplasm ProteinsPhosphoprotein PhosphatasesProtein StabilityCDKN1B protein, humanCyclin-Dependent Kinase Inhibitor p27Matrix Metalloproteinase 2MMP2 protein, humanNeoplasm ProteinsPHLPP2 protein, humanPhosphoprotein Phosphatases

Identifiers

PMID29930380
PMCPMC6202328
OpenAlexW2809046230

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.